Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-002727-24Phase 3
Phase 3, randomised trial of moxifloxacin in bacterial conjunctivitis (BC) (2 arms), sponsored by Alcon Inc. Primary endpoint: Clinical Cure Rate.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-002727-24.